Is Biotest stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Biotest pays dividends. Last time was Monday 13th of May 2024 where the investors holding the stock on Wednesday 8th of May 2024 were paid €0.04 per share. Over the last 23 times between 2000 and 2024, Biotest has paid €5.95 with an average of €0.26 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Biotest 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €22.15, you would have made a profit of €4.95 per share or 22.35%
No, the average daily trading liquidity for Biotest is €898 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Biotest has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.03, the company's ability to pay off the debt is limited. Biotest has a very good net profit margin of 25.26% and should have very high tolerances against inflation.
We have calculated the inflation risk for Biotest to be low [0.45 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.